This artice is free to access.
This is the protocol for a review and there is no abstract. The objectives are as follows:To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
Bennett, T. G., Le Marshall, K., Khan, F., Wark, J. D., & Brand, C. (2012). Denosumab for the treatment and prevention of postmenopausal osteoporosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010011